巴多昔芬 (198481-32-2)
- 常用名巴多昔芬英文名1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol
- 中文别名
巴多昔芬;
- 英文别名
TSE-424;
Bazedoxifene;
1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-;
1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-indol-5-ol;
1-{4-[2-(Azepan-1-yl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol;
Bazedoxifeno;
1-{4-[2-(1-Azepanyl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol;
1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-;
Conbriza;
- CAS号198481-32-2分子量470.603
- 密度1.2±0.1 g/cm3沸点694.4±55.0 °C at 760 mmHg
- 分子式C30H34N2O3熔点N/A
更多
更新时间:1970-01-01 00:00
快速询盘
现货直购
品牌/公司
包装规格
纯度/含量
库存/期货
价格
数量
操作
普西唐
5mg
≥98%
现货
¥652
加入购物车源叶生物
5mg
98%
现货
¥700
加入购物车吉至生化
5mg
98%
现货
¥836
加入购物车陌孚
5mg
≥98%
现货
¥846.72
加入购物车源叶生物
10mg
98%
现货
¥1200
加入购物车普西唐
10mg
≥98%
现货
¥1325
加入购物车陌孚
10mg
≥98%
现货
¥1486.46
加入购物车毕佳索
5mg
98%
现货
¥2000
加入购物车毕佳索
50mg
98%
现货
¥2084
加入购物车源叶生物
25mg
98%
现货
¥2400
加入购物车
价格太高?别走,点击
巴多昔芬 百科资料
- 中文名1-[[4-[2-(氮杂环庚烷-1-基)乙氧基]苯基]甲基]-2-(4-羟基苯基)-3-甲基-吲哚-5-醇
- 英文名1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol
- 中文别名巴多昔芬 |
- 英文别名TSE-424 |Bazedoxifene |1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl- |1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-indol-5-ol |1-{4-[2-(Azepan-1-yl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol |Bazedoxifeno |1-{4-[2-(1-Azepanyl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol |1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl- |Conbriza |
- 描述Bazedoxifene是雌激素受体调节剂(SERM)。
- 相关类别信号通路 >> 其他 >> 雌激素受体/ERR 研究领域 >> 癌症
- 参考文献[1]. Lewis-Wambi JS, et al. The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1. Mol Pharmacol. 2011 Oct;80(4):610-20. [2]. Duggan ST, McKeage K. Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis. Drugs. 2011 Nov 12;71(16):2193-212. [3]. Lello S, Brandi ML, Minisola G et al. Bazedoxifene: literature data and clinical evidence. Clin Cases Miner Bone Metab. 2011 Sep;8(3):29-32. [4]. Komm BS, Chines AA. Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis. 2012 Feb;4(1):21-34.
- 密度1.2±0.1 g/cm3
- 沸点694.4±55.0 °C at 760 mmHg
- 分子式C30H34N2O3
- 分子量470.603
- 闪点373.8±31.5 °C
- 精确质量470.256958
- PSA57.86000
- LogP6.59
- 蒸汽压0.0±2.3 mmHg at 25°C
- 折射率1.622
巴多昔芬 合成路线
共页
巴多昔芬上游产品 0
猜你喜欢
相关产品